Roberts - Google Patents
Atopic Dermatitis in Pediatric PatientsRoberts
View HTML- Document ID
- 5874821444841833604
- Author
- Roberts K
External Links
Snippet
Atopic dermatitis (AD) continues to increase in prevalence. Less than half of AD patients have complete resolution by 7 years of age. In 30% to 40% of patients, this condition persists into adulthood. These statistics reflect poorly on the standard-of-care therapies that fail to …
- 201000008937 atopic dermatitis 0 title abstract description 90
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kim et al. | Dietary effect of lactoferrin-enriched fermented milk on skin surface lipid and clinical improvement of acne vulgaris | |
| Abrahamsson et al. | Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial | |
| Rozé et al. | An α-lactalbumin-enriched and symbiotic-supplemented v. a standard infant formula: a multicentre, double-blind, randomised trial | |
| Lee et al. | Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis | |
| Vaghef-Mehrabany et al. | Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis | |
| Rautava et al. | Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant | |
| Menard et al. | Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport | |
| Mori et al. | Effect of probiotic and prebiotic fermented milk on skin and intestinal conditions in healthy young female students | |
| Zaharoni et al. | Probiotics improve bowel movements in hospitalized elderly patients—The proage study | |
| EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) | Guidance on the scientific requirements for health claims related to the immune system, the gastrointestinal tract and defence against pathogenic microorganisms | |
| US9737575B2 (en) | Use of lactic acid bacteria to treat or prevent eczema | |
| Khan et al. | Atopic dermatitis and nutrition | |
| Finch et al. | Atopic dermatitis and nutrition | |
| CN102791849A (en) | Lactic acid bacterium-containing preparation | |
| JP7407195B2 (en) | Combination of probiotics for the treatment of allergic diseases | |
| JP7296454B2 (en) | Combinations of probiotics for the treatment of inflammation-related gastrointestinal disorders | |
| JP2022160397A (en) | Methods and compositions using bifidobacterium longum to modulate emotional reactivity and treat or prevent sub-clinical mood disturbances | |
| US20130302298A1 (en) | Treatment and prevention of eczema | |
| CA2994352A1 (en) | Methods and compositions using bifidobacterium longum to optimize breastfeeding | |
| JP2010006801A (en) | Lactic acid bacterium formulation and process for its production | |
| WO2011099875A1 (en) | Use of lactic acid bacteria to treat or prevent rhinitis | |
| Roberts | Atopic Dermatitis in Pediatric Patients | |
| Gueniche et al. | Probiotics for skin benefits | |
| CN116744950A (en) | Methods for preventing, delaying or ameliorating atopic diseases | |
| US20240226196A9 (en) | Composition and Use Thereof |